|It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
|Sample-dependent, check data in validation data gallery
20658-1-AP targets PGC1a in WB, IHC, IF, chIP, ELISA applications and shows reactivity with human, mouse samples.
|human, mouse, rat, goat, chicken, zebrafish
|Host / Isotype
|Rabbit / IgG
|peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|Calculated molecular weight
|Observed molecular weight
|GenBank accession number
|Gene ID (NCBI)
|Antigen affinity purification
|PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
|Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.
PPARGC1A, also named as Peroxisome proliferator-activated receptor gamma coactivator 1-alpha, is a 798 amino acid protein, which Contains 1 RRM (RNA recognition motif) domain and localizes in the nucleus. PPARGC1A is transcriptional coactivator for steroid receptors and nuclear receptors. PPARGC1A can regulate key mitochondrial genes that contribute to the program of adaptive thermogenesis and plays an essential role in metabolic reprogramming in response to dietary availability through coordination of the expression of a wide array of genes involved in glucose and fatty acid metabolism. PPARGC1A exists various isoforms and range of molecular weight of isoforms are 30-50 kDa and 90-110 kDa.
AUTACs: Cargo-Specific Degraders Using Selective Autophagy.
Defective mitochondrial ISCs biogenesis switches on IRP1 to fine tune selective mitophagy.
FOXG1 promotes aging inner ear hair cell survival through activation of the autophagy pathway.
Part Fibre Toxicol
Carbon black suppresses the osteogenesis of mesenchymal stem cells: the role of mitochondria.
Oxid Med Cell Longev
Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy.
Cardioprotection of CAPE-oNO2 against myocardial ischemia/reperfusion induced ROS generation via regulating the SIRT1/eNOS/NF-κB pathway in vivo and in vitro.